Caxton Associates (New York)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,025
| Closed | -$1.33M | – | 625 |
|
|
2021
Q2 | $1.33M | Buy |
+8,025
| New | +$1.33M | 0.15% | 42 |
|
|
2020
Q4 | – | Sell |
-3,807
| Closed | -$386K | – | 351 |
|
|
2020
Q3 | $386K | Sell |
3,807
-312
| -8% | -$31.6K | 0.04% | 138 |
|
|
2020
Q2 | $401K | Buy |
+4,119
| New | +$401K | 0.04% | 165 |
|
|
2020
Q1 | – | Sell |
-1,925
| Closed | -$214K | – | 640 |
|
|
2019
Q4 | $214K | Buy |
+1,925
| New | +$214K | 0.03% | 337 |
|
|
2019
Q2 | – | Sell |
-5,133
| Closed | -$566K | – | 558 |
|
|
2019
Q1 | $566K | Buy |
+5,133
| New | +$566K | 0.08% | 119 |
|
|
2018
Q4 | – | Sell |
-6,892
| Closed | -$759K | – | 489 |
|
|
2018
Q3 | $759K | Buy |
+6,892
| New | +$759K | 0.05% | 133 |
|
|
2018
Q2 | – | Sell |
-6,650
| Closed | -$552K | – | 461 |
|
|
2018
Q1 | $552K | Sell |
6,650
-4,654
| -41% | -$386K | 0.03% | 207 |
|
|
2017
Q4 | $1.03M | Buy |
11,304
+5,004
| +79% | +$456K | 0.05% | 159 |
|
|
2017
Q3 | $480K | Hold |
6,300
| – | – | 0.02% | 304 |
|
|
2017
Q2 | $473K | Buy |
+6,300
| New | +$473K | 0.02% | 303 |
|